Skadden is representing Ares Life Sciences in its acquisition of Albion Medical Holdings, Inc., including its wholly owned subsidiary GREER Laboratories, Inc., a leader in allergy immunotherapy in the U.S., announced on March 8.
Skadden is representing Ares Life Sciences in its acquisition of Albion Medical Holdings, Inc., including its wholly owned subsidiary GREER Laboratories, Inc., a leader in allergy immunotherapy in the U.S., announced on March 8.